Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 11:38 PM
NCT ID: NCT02856594
Description: Adverse events were collected via review of the electronic medical record or by phone call at 30, 90 or 180 days.
Frequency Threshold: 0
Time Frame: Adverse events were evaluated until discharge from the hospital. Mortality was assessed until 180 days postoperatively.
Study: NCT02856594
Study Brief: Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dexmedetomidine-induced Sleep Precedex (Dexmedetomidine) intervention: Intravenous administration of 1mcg/kg over 40 minutes. Dexmedetomidine: Dexmedetomidine 4 None 0 188 0 188 View
Placebo Placebo of normal saline: Intravenous administration of normal saline over 40 minutes. Placebo: Placebo 4 None 0 206 0 206 View
Serious Events(If Any):
Other Events(If Any):